More from the company: WntResearch: Ny forskning visar att Foxy-5 motverkar spridning av prostatacancerceller

Press release from Companies: Henrik Lawaetz Resigns as CEO of WntResearch

Press release from Companies: Henrik Lawaetz Resigns as CEO of WntResearch

Press release from Companies: Henrik Lawaetz Resigns as CEO of WntResearch

Press release from Companies: WntResearchs vd Henrik Lawaetz lämnar sin position

Press release from Companies: WntResearchs vd Henrik Lawaetz lämnar sin position

Press release from Companies: WntResearchs vd Henrik Lawaetz lämnar sin position

Reports: WntResearch AB lämnar delårsrapport Q2 April-Juni 2017

Reports: WntResearch AB lämnar delårsrapport Q2 April-Juni 2017

Reports: WntResearch AB lämnar delårsrapport Q2 April-Juni 2017

Press release from Companies: WntResearch announces that the last patient has been treated in a Phase 1b study with the drug candidate Foxy-5

Press release from Companies: WntResearch announces that the last patient has been treated in a Phase 1b study with the drug candidate Foxy-5